Imatinib therapy in a patient with suspected chronic neutrophilic leukemia and FIP1L1-PDGFRA rearrangement.

作者信息

Jain Nitin, Khoury Joseph D, Pemmaraju Naveen, Kollipara Praveen, Kantarjian Hagop, Verstovsek Srdan

机构信息

Department of Leukemia, MD Anderson Cancer Center, Houston, TX.

出版信息

Blood. 2013 Nov 7;122(19):3387-8. doi: 10.1182/blood-2013-07-516500.

DOI:10.1182/blood-2013-07-516500

PMID:24203930

Abstract

摘要

相似文献

Imatinib therapy in a patient with suspected chronic neutrophilic leukemia and FIP1L1-PDGFRA rearrangement.

Blood. 2013 Nov 7;122(19):3387-8. doi: 10.1182/blood-2013-07-516500.

Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy.

Br J Haematol. 2014 Jun;165(5):583. doi: 10.1111/bjh.12742. Epub 2014 Jan 24.

Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.

Am J Hematol. 2014 Jan;89(1):115. doi: 10.1002/ajh.23588. Epub 2013 Oct 15.

Concomitant FIP1L1-PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib.

Leuk Lymphoma. 2011 Feb;52(2):335-8. doi: 10.3109/10428194.2010.534210.

Detection of FIP1L1-PDGFRA fusion by FISH.

Br J Haematol. 2007 Aug;138(3):279. doi: 10.1111/j.1365-2141.2007.06637.x. Epub 2007 Jun 3.

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia.

J Hematol Oncol. 2014 Mar 27;7:26. doi: 10.1186/1756-8722-7-26.

[Synchronous detection of T-cell clonality and FIP1L1-PDGFRA fusion gene in a hypereosinophilic syndrome].

Rev Med Interne. 2011 May;32(5):e66-8. doi: 10.1016/j.revmed.2010.06.003. Epub 2010 Jul 14.

Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia.

Leuk Lymphoma. 2013 Aug;54(8):1788-90. doi: 10.3109/10428194.2012.749469. Epub 2012 Dec 26.

Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib.

Br J Haematol. 2006 Jan;132(2):123. doi: 10.1111/j.1365-2141.2005.05698.x.

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.

Haematologica. 2007 Sep;92(9):1173-9. doi: 10.3324/haematol.11420. Epub 2007 Aug 1.

引用本文的文献

Hematological Neoplasms with Eosinophilia.

Cancers (Basel). 2024 Jan 12;16(2):337. doi: 10.3390/cancers16020337.

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia.

J Hematol Oncol. 2014 Mar 27;7:26. doi: 10.1186/1756-8722-7-26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验